Nuclear IL-33 regulates cytokinesis and cell motility in normal human epidermal keratinocytes

J Dermatol Sci. 2022 Feb;105(2):113-120. doi: 10.1016/j.jdermsci.2022.01.006. Epub 2022 Jan 25.

Abstract

Background: IL-33 is a dual-functional molecule; it acts as a cytokine to enhance type 2 inflammation, and as a nuclear factor. The roles of nuclear IL-33 are not yet fully understood.

Objective: We aimed to investigate the role of IL-33 in normal human epidermal keratinocytes (NHEKs).

Methods: We utilized RNA interference to knock down cellular IL-33.

Results: The IL-33-knockdown (KD) cells showed decreased BrdU incorporation and decreasing tendency in RhoA activity and decreased ECT2 oncogene expression, compared to the controls. Supplementation of IL-33 expression utilizing adenovirus vector recovered the BrdU incorporation in IL-33-KD cells. Increased number of G2/M phase cells and binucleated cells were observed among the KD cells. Overtime observation revealed that IL-33-KD cells could not divide properly, formed binucleated cells, and were less motile than control cells.

Conclusion: IL-33 KD in NHEKs affected the division and motility, probably by slightly decreasing the RhoA activity by attenuating ECT2 expression.

Keywords: Cell division; Cell proliferation; Interleukin-33; Keratinocyte.

MeSH terms

  • Cell Movement*
  • Cells, Cultured
  • Cytokinesis*
  • Epidermis / metabolism
  • Humans
  • Interleukin-33* / metabolism
  • Keratinocytes* / metabolism
  • Proto-Oncogene Proteins / metabolism
  • rhoA GTP-Binding Protein

Substances

  • ECT2 protein, human
  • IL33 protein, human
  • Interleukin-33
  • Proto-Oncogene Proteins
  • RHOA protein, human
  • rhoA GTP-Binding Protein